​TOPIC A: Bioethics: Genetic Modification

 

As science pushes the boundaries of what’s possible, genetic modification presents both remarkable opportunities and profound ethical dilemmas. This committee will explore the bioethical implications of altering genetic material in humans, animals, and plants. Delegates will debate the use of technologies like CRISPR, considering their potential to cure genetic diseases, enhance human traits, and improve food security, while also addressing concerns about equity, consent, unintended consequences, and the definition of “natural.” Should there be limits to how far science can go—or is genetic modification a necessary step toward a healthier, more advanced future?

​

TOPIC B:  Use of personal data by Corporations  

​

In the digital age, personal data has become one of the most valuable resources—and one of the most contested. This committee will examine how corporations collect, use, and sometimes exploit users’ data for purposes ranging from targeted advertising to algorithm development. Delegates will debate issues of privacy, transparency, consent, and accountability, as well as the role of regulation in protecting individuals’ rights. Should companies have the freedom to use personal data to innovate and grow, or should stronger limits be enforced to safeguard personal autonomy in a connected world?